Solvemed Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
36
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$3.61M
- Investors
-
13
Solvemed General Information
Description
Developer of a neuroscience artificial intelligence system designed to redefine patient care and drug discovery. The company offers proprietary machine learning technology to develop novel diagnostic-predictive digital biomarkers for neurodegenerative diseases, enabling patients and the healthcare industry to have early diagnosis and monitoring tools.
Contact Information
Website
www.solvemed.aiCorporate Office
- 16192 Coastal Highway
- Lewes, DE 19958
- United States
Corporate Office
- 16192 Coastal Highway
- Lewes, DE 19958
- United States
Solvemed Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Seed Round | 05-Oct-2022 | $3.61M | Completed | Generating Revenue | ||
| 2. Accelerator/Incubator | 01-Jan-2021 | Completed | Generating Revenue | |||
| 1. Seed Round | 17-Dec-2020 | $770K | $770K | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Solvemed Patents
Solvemed Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260182834-A1 | System and method for ambient-light-corrected computational pupillometry | Pending | 31-Dec-2024 | ||
| US-20260182835-A1 | System and method for ambient-light-corrected computational pupillometry | Pending | 31-Dec-2024 | ||
| WO-2026147908-A1 | System and method for ambient-light-corrected computational pupillometry | Pending | 31-Dec-2024 | ||
| WO-2025133409-A1 | A method for training a machine learning model for automatically detecting abnormal pupil behaviour based on assessing pupil reactivity invulnerable to external light conditions, a computer program comprising instructions thereof, and a system implementing the model | Inactive | 22-Dec-2023 | ||
| EP-4574018-A1 | A method for training a machine learning model for automatically diagnosing abnormal pupil behaviour based on assessing pupil reactivity invulnerable to external light conditions, a computer program comprising instructions thereof, and a system implementing the model | Inactive | 22-Dec-2023 | A61B3/112 |
Solvemed Signals
Solvemed Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| APEX Ventures | Venture Capital | Minority | ||
| Atmos Ventures | Venture Capital | Minority | ||
| Atomico (UK) Partners | Venture Capital | Minority | ||
| Cambridge Angels | Angel Group | Minority | ||
| ff Venture Capital | Venture Capital | Minority |
Solvemed FAQs
-
When was Solvemed founded?
Solvemed was founded in 2019.
-
Where is Solvemed headquartered?
Solvemed is headquartered in Lewes, DE.
-
What is the size of Solvemed?
Solvemed has 36 total employees.
-
What industry is Solvemed in?
Solvemed’s primary industry is Other Healthcare Technology Systems.
-
Is Solvemed a private or public company?
Solvemed is a Private company.
-
What is Solvemed’s current revenue?
The current revenue for Solvemed is .
-
How much funding has Solvemed raised over time?
Solvemed has raised $4.38M.
-
Who are Solvemed’s investors?
APEX Ventures, Atmos Ventures, Atomico (UK) Partners, Cambridge Angels, and ff Venture Capital are 5 of 13 investors who have invested in Solvemed.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process